Two research facilities with cutting-edge technologies and expertise are dedicated to support scientists at CeMM, the Medical University of Vienna as well as other cooperation partners:

The Biomedical Sequencing Facility (BSF) is Austria’s first technology platform dedicated to next generation sequencing in biomedicine and is thus expected to play a catalyzing role in the country’s development of genomic medicine.

The Molecular Discovery Platform empowers the discovery and characterization of bioactive molecules, including proteins, metabolites, and novel synthetic compounds. State-of-the art instrumentation and scientific expertise in liquid chromatography-mass spectrometry, high-throughput screening and high-content analysis underlies the technology-driven approach.